Citigroup’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-2,875
| Closed | -$857 | – | 5085 |
|
2023
Q2 | $857 | Buy |
2,875
+1,148
| +66% | +$342 | ﹤0.01% | 4589 |
|
2023
Q1 | $747 | Sell |
1,727
-2,683
| -61% | -$1.16K | ﹤0.01% | 4446 |
|
2022
Q4 | $5.2K | Sell |
4,410
-6,251
| -59% | -$7.38K | ﹤0.01% | 4295 |
|
2022
Q3 | $25K | Sell |
10,661
-244
| -2% | -$572 | ﹤0.01% | 3949 |
|
2022
Q2 | $24K | Buy |
10,905
+5,189
| +91% | +$11.4K | ﹤0.01% | 4207 |
|
2022
Q1 | $55K | Buy |
+5,716
| New | +$55K | ﹤0.01% | 3989 |
|